tiprankstipranks
Trending News
More News >
Ambiq Micro, Inc. (AMBQ)
NYSE:AMBQ
US Market

Ambiq Micro, Inc. (AMBQ) AI Stock Analysis

Compare
67 Followers

Top Page

AMBQ

Ambiq Micro, Inc.

(NYSE:AMBQ)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 5.2)
Rating:46Neutral
Price Target:
$30.00
▼(-2.47% Downside)
Action:ReiteratedDate:01/31/26
The score is primarily held back by weak financial performance, driven by persistent losses and negative operating cash flow despite revenue growth and low leverage. Technicals are neutral-to-soft with mixed momentum signals, and valuation is unattractive due to a negative P/E and no dividend yield.
Positive Factors
Low leverage and strong equity position
A low debt load and healthy equity ratio provide lasting financial flexibility, reducing default risk and enabling continued investment in product development and go-to-market activities. This structural balance-sheet strength supports strategic options during semiconductor cyclicality.
Sustained revenue growth (16% YoY)
Recurring mid-teens revenue growth shows durable market traction for Ambiq's products. Continued top-line expansion can enable operating leverage over time, improving gross margin absorption and positioning the company to scale R&D and customer support without relying solely on external funding.
Focused ultra-low-power product specialization
A clear technical niche in ultra-low-power MCUs and Sub-GHz wireless addresses structural demand in wearables, IoT, and battery-constrained devices. This specialization creates a durable competitive advantage through differentiated IP, licensing potential, and stronger product stickiness with OEM customers.
Negative Factors
Persistent negative profitability
Ongoing negative margins indicate structural challenges in cost base, pricing, or product mix that limit the firm's ability to self-fund growth. Persistent losses hurt ROE and reduce retained-capital accumulation, forcing reliance on external financing or slower, equity-dilutive growth strategies.
Negative operating cash flow
Sustained negative operating cash flow undermines internal liquidity and constrains investment in production, inventory, and R&D. Even with some free-cash-flow improvements, persistent OCF deficits create a structural dependency on external capital and limit long-term operational autonomy.
Recent equity offering and selling-stockholder sale
Large share offerings and selling-stockholder activity can reflect limited internal funding or shareholder liquidity needs. Structurally, increased share supply and potential future raises can dilute ownership, complicate long-term investor alignment, and signal reliance on external capital for sustaining operations.

Ambiq Micro, Inc. (AMBQ) vs. SPDR S&P 500 ETF (SPY)

Ambiq Micro, Inc. Business Overview & Revenue Model

Company DescriptionAmbiq Micro, Inc. develops ultra-low-power integrated circuits for power-sensitive applications. It develops subthreshold power-optimized technology based on ultra-low-power real-time clock and microcontroller products for application in wearables, smart cards, wireless sensors, and Internet-of-Things (IoT) products. The company's flagship products include Apollo, a system on a chip for edge AI devices with host processors capable of software-based AI computations and Atomiq, targeting AI applications to provide AI acceleration along with new memory innovations. The company also offers technical support services. It offers products through sales representatives. Ambiq Micro, Inc. was formerly known as Cubiq Microchip, Inc. and changed its name to Ambiq Micro, Inc. in October 2012. The company was incorporated in 2010 and is based in Austin, Texas with additional offices in Shanghai and Shenzhen, China; Hsinchu, Taiwan; and Singapore.
How the Company Makes MoneyAmbiq Micro generates revenue primarily through the sales of its semiconductor products, including microcontrollers and wireless chips, to manufacturers in various industries. The company benefits from a diverse revenue model that includes direct sales to original equipment manufacturers (OEMs) and partnerships with distributors. Key revenue streams come from licensing agreements, royalties from intellectual property, and customized solutions for specific applications that cater to clients' unique needs. Significant partnerships with major technology firms and integration into popular consumer devices further enhance Ambiq's market reach and contribute to its earnings.

Ambiq Micro, Inc. Earnings Call Summary

Earnings Call Date:Sep 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted Ambiq's strategic shift away from the Chinese market, successful IPO, and increased gross profit, which were offset by a year-over-year revenue decline and increased net loss. The company is focusing on expanding into new markets and introducing new products, suggesting a positive long-term outlook despite current challenges.
Q2-2025 Updates
Positive Updates
Increased Revenue and Gross Profit
Revenue for Q2 2025 was $17.9 million, up from $15.7 million in Q1, driven by increased customer demand and favorable product mix. Gross profit also increased to $7.6 million, representing 42.7% of revenue, up from $6.7 million or 32.9% a year ago.
Successful IPO and Financial Position
The company completed an IPO, raising $97.2 million in net proceeds. Cash and cash equivalents were $47.5 million at the end of Q2 2025.
Strategic Shift in Market Focus
Net sales to end customers in Mainland China decreased from 42% in Q2 2024 to 11.5% in Q2 2025, reflecting a strategic shift towards higher-value opportunities outside of China.
New High-Profile Customer Win
Ambiq announced a significant design win with Whoop for their newest fitness tracker product line, showcasing the company's capability in the wearables market.
Negative Updates
Year-over-Year Revenue Decline
Revenue decreased from $20.3 million in Q2 2024 to $17.9 million in Q2 2025, attributed to the strategic decision to diversify away from China.
Increased Net Loss
Net loss for Q2 2025 was $8.5 million, slightly higher than the $8.3 million loss in Q1 2025, although improved from the $10.6 million loss in Q2 2024.
Challenges in Transitioning Markets
The transition from a China-focused revenue model to more diverse markets led to short-term revenue declines and increased operating expenses.
Company Guidance
During Ambiq Micro's second quarter 2025 earnings call, the company provided financial guidance for the third quarter of 2025, expecting revenue to range between $17.5 million and $18 million. The non-GAAP loss per share is anticipated to be between $0.35 and $0.28, based on a weighted average post-IPO share count of approximately 18.2 million shares. The call highlighted that Ambiq's strategic shift away from sales in Mainland China contributed to a decrease from 42% of net sales in Q2 2024 to 11.5% in Q2 2025. The company also reported a second quarter revenue of $17.9 million, a sequential increase from $15.7 million in Q1 2025, although a decline from $20.3 million in Q2 2024. Ambiq's non-GAAP gross profit was $7.6 million, or 42.7% of revenue, up from $6.7 million in the previous year. The call emphasized the company's focus on expanding its presence in new markets and geographies and the development of its Atomic product line to capture edge AI opportunities.

Ambiq Micro, Inc. Financial Statement Overview

Summary
Revenue growth improved (+16%), and leverage risk appears low, but profitability remains weak with persistently negative net profit, EBIT, and EBITDA margins. Cash flow quality is also a concern given negative operating cash flow, despite some improvement in free cash flow trends.
Income Statement
45
Neutral
Ambiq Micro, Inc. has shown some improvement in revenue growth with a 16% increase in the latest year. However, the company continues to face challenges with profitability, as evidenced by negative net profit margins and EBIT margins. The gross profit margin has slightly improved but remains below industry averages. The consistent negative EBIT and EBITDA margins indicate ongoing operational inefficiencies.
Balance Sheet
55
Neutral
The company maintains a strong equity position with a low debt-to-equity ratio, indicating minimal leverage risk. However, the return on equity remains negative, reflecting ongoing losses. The equity ratio is healthy, suggesting a solid asset base relative to equity. Despite these strengths, the negative ROE highlights profitability challenges.
Cash Flow
40
Negative
Ambiq Micro, Inc. has shown some improvement in free cash flow growth, but operating cash flow remains negative, indicating cash flow challenges. The free cash flow to net income ratio is positive, suggesting that cash flow generation relative to net income is somewhat stable. However, the negative operating cash flow to net income ratio highlights ongoing cash flow management issues.
BreakdownTTMDec 2024Dec 2023Dec 2021Dec 2020
Income Statement
Total Revenue51.77M76.07M65.54M91.01M50.97M
Gross Profit23.24M24.29M19.44M30.77M21.57M
EBITDA-20.97M-34.37M-43.61M-21.85M-18.29M
Net Income-25.78M-39.66M-50.33M-25.34M-25.22M
Balance Sheet
Total Assets186.73M104.28M72.43M105.13M99.68M
Cash, Cash Equivalents and Short-Term Investments146.49M60.98M27.32M25.92M65.05M
Total Debt771.00K966.00K1.02M0.000.00
Total Liabilities16.94M18.53M13.30M16.12M7.38M
Stockholders Equity169.79M85.75M59.13M89.01M92.30M
Cash Flow
Free Cash Flow-19.43M-25.16M-29.98M-57.50M-39.23M
Operating Cash Flow-15.58M-21.43M-26.96M-52.88M-34.64M
Investing Cash Flow-4.85M-3.73M-3.02M-4.62M-4.59M
Financing Cash Flow105.90M58.84M31.77M18.20M94.06M

Ambiq Micro, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$19.39B121.5512.95%32.58%-173.04%
67
Neutral
$56.80B28.3921.01%1.79%-6.81%-23.16%
67
Neutral
$6.75B-102.96-5.97%47.10%64.29%
64
Neutral
$8.86B22.906.49%4.37%-2.18%-16.84%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
$40.21B-258.11-1.09%2.79%-23.36%-131.15%
46
Neutral
$644.53M-15.59
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AMBQ
Ambiq Micro, Inc.
29.30
-14.55
-33.18%
MTSI
MACOM Technology Solutions Holdings
241.01
131.25
119.58%
MCHP
Microchip
71.39
14.94
26.46%
NXPI
NXP Semiconductors
215.25
7.99
3.85%
SLAB
Silicon Laboratories
203.64
69.68
52.02%
SWKS
Skyworks Solutions
58.15
-5.11
-8.08%

Ambiq Micro, Inc. Corporate Events

Executive/Board Changes
Ambiq Micro Appoints Bernard Banks to Expanded Board
Positive
Jan 8, 2026

Effective January 5, 2026, Ambiq Micro, Inc. expanded its board of directors from six to seven members and appointed leadership expert Dr. Bernard B. Banks as a Class III director, with a term running until the 2028 annual meeting of stockholders, and as a member of the board’s Audit Committee. Banks, currently Director of Rice University’s Doerr Institute for New Leaders and a former U.S. Army Brigadier General with extensive academic and leadership credentials, will receive standard non‑employee director compensation, has entered into the same form of indemnification agreement as existing directors, and joins the board without any family ties, appointment arrangements, or related‑party transactions with the company.

The most recent analyst rating on (AMBQ) stock is a Hold with a $32.00 price target. To see the full list of analyst forecasts on Ambiq Micro, Inc. stock, see the AMBQ Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 31, 2026